Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.7551/978-0-262-32621-6-CH109 | ||||
| Año | 2014 | ||||
| Tipo | proceedings paper |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
In (Veliz-Cuba and Stigler, 2011) the authors proposed a Boolean model for the lac operon in Escherichia coli that is capable of predicting the operon being ON, OFF and bistable when the update schedule is the parallel one. We complement this work by using theoretical and algorithmic tools that allow us to know which are the configurations that converge to a fixed point or limit cycle (set namely attractor basin) for each deterministic update schedule. We show that, when bistability appears, about 70% of the dynamics have only the steady states ON and OFF. This latest having an attractor basin of an average size about 8 times bigger than that of ON. In the other 30%, the proportion is balanced between ON/OFF basins but the basins of limit cycles sum up, in average, about 5 times more than that of ON and OFF respectively. The techniques presented in this work are general and can be used to analyze other Boolean models.
| Revista | ISSN |
|---|---|
| Life With Ore Deposits On Earth, Proceedings Of The 15 Th Sga Biennial Meeting, 2019, Vols 1 4 | ***************** |
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Montalva, Marco | Hombre |
Universidad Adolfo Ibáñez - Chile
|
| 2 | RUZ-HEREDIA, GONZALO ANDRES | Hombre |
Universidad Adolfo Ibáñez - Chile
|
| 3 | GOLES-CHACC, ERIC ANTONIO | Hombre |
Universidad Adolfo Ibáñez - Chile
|
| 4 | Sayama, H | - | |
| 4 | Sayama, H | - | |
| 5 | Rieffel, J | - | |
| 5 | Rieffel, J | - | |
| 6 | Risi, S | - | |
| 6 | Risi, S | - | |
| 7 | Doursat, R | - | |
| 7 | Doursat, R | - | |
| 8 | Lipson, H | - | |
| 8 | Lipson, H | - |
| Agradecimiento |
|---|
| This work was supported by Fondecyt 3130466 (M.M.), Fondecyt 11110088 (G.A.R.), Fondecyt 1140090 (E.G.). |
| This work was supported by Fondecyt 3130466 (M.M.), Fondecyt 11110088 (G.A.R.), Fondecyt 1140090 (E.G.). |
| This work was supported by Fondecyt 3130466 (M.M.), Fondecyt 11110088 (G.A.R.), Fondecyt 1140090 (E.G.). |